Cell Therapeutics Inc (NASDAQ:CTIC) average recommendation is buy with average target price of $4.39. Cell Therapeutics Inc (NASDAQ:CTIC) stock opened at $0.25 in last trading session, and closed at $4.01, trading in the range of $3.84 – $4.25. The stock showed a positive weekly performance of 44.18%.
Pfizer Inc. (NYSE:PFE) announced that a new smoking-cessation clinical study assessing the efficacy and safety of varenicline CHANTIX, CHAMPIX met its primary and secondary endpoints. This is the first study of varenicline using the approach of reducing smoking prior to quitting. Smokers in this study were unwilling or unable to abruptly quit smoking within four weeks, but were willing to reduce smoking over a period of 12 weeks, with the goal of quitting by the end of that period. Pfizer Inc. (NYSE:PFE) shares closed at $31.23 on last trade day, by gaining 0.45%. Stock 52 week range is $26.34 – $32.50. Company’s market capitalization is $202.40 billion.
Amarin Corporation plc (ADR) (NASDAQ:AMRN)’s shares fell more than 26 percent after U.S. health regulators rejected a preset testing process that was critical to the company seeking broader use of its blood fat-lowering drug. The Irish drugmaker said it planned to appeal the decision. The company may have to drop its bid to treat a wider population — for which it is currently conducting a large, multi-year study — if it doesn’t succeed, the company said in a conference call. Amarin Corporation plc (ADR) (NASDAQ:AMRN) stock down -23.79% and finished the last session at $1.73. The EPS of the stock remained -1.03. Company’s market capitalization is $298.67 billion.
Galena Biopharma Inc (NASDAQ:GALE)was falling 10.99% to $6.23 on Tuesday despite two analyst upgrades. Needham & Company reiterated a “buy” rating and boosted the target price to $9 from $3.50. Galena Biopharma Inc (NASDAQ:GALE) stock opened at $7.05 in last trading session and closed at $6.38. The 52 week range of the stock is $1.65 – $7.77 and the day range was $5.55 – $7.15.